Delivery Order SPE2DB22D2005-SPE2DB25FJJN4

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,752.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a medical product, with a completion date of November 13, 2023. The contract is a Firm Fixed Price (FFP) arrangement and was not designated with a set-aside requirement, indicating open...
This federal contract award, valued at $1,661.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for "ESTROGEN-METHYLTESTOS F.S. TAB 100S" and has an ultimate completion date of August 28, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is part of a larger...
This federal contract award is a delivery order valued at $2,468.80 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the purchase of Estrogen-Methyltestos F.S. Tablets in quantities of 100s. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,230.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of "ESTROGEN-METHYLTESTOS F.S. TAB 100S," a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of September 6, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $97,663.02 firm fixed-price delivery order contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,837.41 and is a Firm Fixed Price Delivery Order that runs through March 4, 2024. The contract provides medical supplies and pharmaceutical products, including tablets, to support military healthcare programs. This contract is part of a larger $999,999,999 Indefinite...
This federal contract award, valued at $111,908.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,137.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $8,560.93 with a firm fixed price pricing type. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,082.10, is a Delivery Order with a Firm Fixed Price pricing type, and the Ultimate Completion Date is January 29, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJJN4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,108.55, is a Firm Fixed Price Delivery Order to provide Estrogen-Methyltestos H.S. Tablets in 100 count sizes. The contract has an ultimate completion date of March 11, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/9/25, 9:46 AM